Exploratory biomarker analysis of phase III ASTRUM-004 study: Serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer

Zhou C., Hu Y., Arkania E., Kilickap S., Ying K., Xu F., ...More

ANNALS OF ONCOLOGY, 2024 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Publication Date: 2024
  • Doi Number: 10.1016/j.annonc.2024.08.160
  • Journal Name: ANNALS OF ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Hacettepe University Affiliated: Yes